Expert in Early Phase Therapeutics Joins NYU Langone Health as Associate Director for Clinical Research at Perlmutter Cancer Center
July 02, 2020
July 02, 2020
NEW YORK, July 2 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
Janice M. Mehnert, MD, a nationally recognized expert in early phase therapeutics and the treatment of skin malignancies, has been appointed associate director for clinical research at NYU Langone Health's Perlmutter Cancer Center. She assumes her post July 1, 2020.
Dr. Mehnert was previously an associate professor of medicine at Rut . . .
Janice M. Mehnert, MD, a nationally recognized expert in early phase therapeutics and the treatment of skin malignancies, has been appointed associate director for clinical research at NYU Langone Health's Perlmutter Cancer Center. She assumes her post July 1, 2020.
Dr. Mehnert was previously an associate professor of medicine at Rut . . .